课题基金 / 基金详情

Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty (EPCAT II)

Extended Venous Thromboembolism Prophylaxis Comparing Rivaroxaban to Aspirin Following Total Hip and Knee Arthroplasty (EPCAT II)
全髋关节和膝关节置换术后延长静脉血栓栓塞预防比较利伐沙班与阿司匹林 (EPCAT II)
批准号：
254987
负责人：
Anderson David R
金额：
$221.82万
依托单位：
Nova Scotia Health Authority (Halifax)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2012
资助国家：
加拿大
项目状态：
已结题
起止时间：
2012-03-01 至 2016-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=254987&lang=en
关键词：
Double-Dummy Extended Venous Thromboembolism Prophylaxis Out Of Hospital Randomized Total Hip Arthroplasty Total Knee Arthroplasty

项目摘要

项目成果

Anderson David R的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Blood clots in the legs and lungs are common complications following hip and knee replacement surgery. Guidelines state to give anticoagulants (blood thinners) for up to 14 days after knee replacement and 35 days after hip replacement. In this study we in
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Maritime SPOR SUPPORT Unit Phase II Proposal
海外基金